Bristol-Myers Squibb (BMY) Tops Q2 EPS by 14c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at BMO Capital
July 27, 2018 8:21 AM EDTBMO Capital raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $51.00) while maintaining a Market Perform rating.
Analyst Alex Arfaei commented, "Bristol had a good 2Q but expectations had risen, which, coupled with untimely (CHMP RCC) news, pressured BMY. The... More
Bristol-Myers Squibb Co. (BMY) PT Raised to $63 at Morgan Stanley
July 27, 2018 7:37 AM EDTMorgan Stanley raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $63.00 (from $58.00) while maintaining a Equalweight rating.
... More